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We have recently described a cell type-specific surface (SF) antigen (1) that is
deleted in chick fibroblasts transformed by Rous sarcoma virus (2). SF antigen is
a major surface component and makes up about 0.5% of the total protein of
normal cultured fibroblasts. The antigen is shed from cells and is present in
circulation (serum, plasma). The molecular equivalents of both cellular and
serum SF antigen are distinct large polypeptides (2, 3), one ofwhich (SF210, mol
wt 210, 000) is glycosylated and on the cell surfacehighly susceptible to proteases
as well as being accessible to surface iodination .' Immunofluorescence and
scanning electron microscopy have indicated that in chicken fibroblasts the
antigen is located in fibrillar structures of the cell surface, membrane ridges, and
processes (4). The external transformation-sensitive molecules found by the
lactoperoxidase orthe galactose oxidase method in fibroblasts (reviewed in ref. 5)
seem to represent one of the SF antigen polypeptides (SF210) of the different
species studied. An antigen analogous to the chicken SF antigen is present in
human fibroblasts and in human serum (6). We have recently shown (7) that
human SF antigen is identical to what has been known as the "cold insoluble
globulin" (8) and that it shows affinity towards fibrin and fibrinogen.
We show here that human fibroblasts transformed with simian virus 40 (SV40)
lack SF antigen. The transformed cells produce this antigen but it is not retained
on the surface ofthese cells. This creates a major difference between the surfaces
of normal and malignant cells.
Material and Methods
Cell Cultures.
￿
All cell lines were grown at 37°C in Eagle's basal medium plus 10% fetal calf serum.
Two established SV40-transformed human fibroblast lines, WI-38/VA13 (9) and WI-SV40 (provided
by Dr. S. Stenman, University of Helsinki) were used. They are known not to produce SV40 virus.
TheSV40-specific nuclear Tantigen (kindly tested by Dr. S. Stenman) was positive in 100% ofcells of
both lines. The origin of the other cell lines was reported earlier (6) .
Antibodies .
￿
Anti-SF antisera were produced using a modification of the previously published
technique (6) . A sheep was immunized with SF antigen solubilized with matrix-bound papain
(Enzite-EMA, Miles-Yeda, Rehovot, Israel) from the surface of cultured human fibroblasts. The
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Cancer Foundation, and the Sigrid Juselius Foundation .
' Keski-Oja, J., A. Vaheri, and E. Ruoslahti. 1975. Fibroblast surface antigen (SF): the external
glycoprotein lost in proteolytic stimulation andmalignant transformation. Manuscript submitted for
publication.
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solubilized material was treated with antipapain antibodies coupled (10) to Sepharose 413 particles
(Pharmacia Fine Chemicals, Inc., Sweden) to remove papain released from the enzyme preparation,
and passed through a Sephadex G-200 (Pharmacia) gel filtration column . The SF antigen containing
fractions from this separation were used for immunization. The resulting antisera gave a single
precipitation line in immunodiffusion against papain-released material and urea-Triton X-100
extracts (2) from fibroblasts and against human serum. To ensure specificity for SF antigen at the
level of immunofluorescence and radioimmunoassay, the antiserum wasabsorbed with calf serum (a
constituent of the cell culture medium) and humanleukocytes obtained from buffy coat. Antibodies
were isolated from the antiserum by binding to Sepharose 413 to which normal human serum proteins
(including SF antigen) had been conjugated (10) and by subsequent elution of the bound antibodies
with 8 M urea (11) .
Irmunofuorescence. The cultures were grown on cover slips, rinsed with phosphate-buffered
saline (PBS), fixed with formaldehyde (3.5%, 20 min, room temperature), washed with PBS, treated
with acetone (10 min, -20°C), and air dried. SF antigen was demonstrated and localized by direct
immunofluorescence using anti-SF-sheep IgG conjugated with fluorescein isothiocyanate (fluores-
cein/protein molar ratio 2.3) and a Leitz Orthoplan microscope (E. Leitz, W. Germany) .
Samples tested for the capacity to inhibit SF antigen immunofluorescence were incubated with the
fluorescenated antibody preparation for 60 min at 37°C. SF antigen (cold insoluble globulin; ref. 7)
for fluorescence inhibition tests was purified from human plasma by cryoprecipitation, DEAE
cellulose chromatography (8), and isoelectric focusing. The preparations gave a single line of
precipitation against anti-SF and anti-whole human serum in immunodiffusion andwere adjusted to
100 ug/ml of protein for inhibition tests .
Radioimmunoassay . Purified SF antigen is not completely soluble in aqueous buffers and we
experienced difficulties in trying to set up a radioimmunoassay based on iodinated SF antigen. The
assay we used consisted of binding of '251-labeled (12) anti-SF antibodies to glutaraldehyde-fixed
(1.5%, 30 min) fibroblast monolayers on 35-mm plates and inhibition of the binding by SF
antigen-containing samples . Serial dilutions of normal human serum were used as standards. SF
antigen concentrations are given as relative units where 1,000 U equal the antigen concentration of
undiluted standard human serum in the assay.
Results
Immunofluorescent staining with anti-SF antibodies revealed that SF antigen
had a highly nonrandom fibrillar distribution on the surface of normal human
fibroblasts fixed with formaldehyde and acetone (Fig. 1) . When live fibroblast
cultures were stained at f0° and then fixed or when glutaraldehyde-fixed
cultures (1 .5%, 30 min) were examined, a similar pattern of fluorescence was seen
in agreement with the surface localization of the antigen. SV40-transformed cells
(either WI-38/VA13 or WI-SV40) had no detectable antigen (Fig. 1) . Old dense
cultures often had traces of SF antigen located between the cells, but the cells
themselves were negative. The staining reactions were totally blocked by purified
human SF antigen or normal humanserum but not by bovine or chicken serum.
Radioimmunoassay showed the presence of SF antigen in urea-detergent
extracts of normal fibroblasts but not extracts of other normal cells or of any of
the transformed cell lines tested (Table I) .
Radioactive anti-SF antibodies bound to normal cells whereas binding to
transformed cultures did not exceed the values obtained with SF antigen-nega-
tive (nonfibroblast) cells. The SF antigen content at the surface of normal
cultures as measured with this technique was at least 10 times higher per mg cell
protein than that in transformed cultures . Immunodiffusion identified SF
antigen in urea-Triton X-100 extracts of normal fibroblasts and serum in
agreement with our previous observations (7). Extracts of transformed cells532
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FIG. 1 .
￿
Immunofluorescent staining for human SF antigen in cultures of normal (left) and
SV40-transformed (right) human fibroblasts . Fixation with formaldehyde and acetone .
showed no detectable reaction with anti-SF antiserum . SF antigen was also
found by immunodiffusion in concentrated culture fluid samples of normal
fibroblasts and also from those of transformed cells (Fig . 2) . Quantitation by
radioimmunoassay showed that the culture fluids of SV40-transformed cells
contained about 30-40% of the SF antigen in fluids of normal cells calculated per
mg cellular protein (Table I) .
Discussion
These and previous results on chicken, hamster, and mouse (reviewed in ref. 5)
fibroblasts show that a major cell surface component is lost when fibroblasts are
transformed . The present result on the human fibroblast-SV40 system indicate
that both normal and transformed cells produce the antigen but the latter do not
retain the antigen on the surface . The phenomenon is not restricted to cell lines
transformed experimentally by viruses . Our recent experiments indicate that
whereas cultured normal human fibroblasts and glia cells contain SF antigen,
established lines of the corresponding malignant cells, sarcomas, and gliomas doTABLE I
SF Antigen in Extracts of Cultured Human Cells in Culture Media;
Inhibition of Binding of ...I-Labeled anti-SF Antibodies to
Glutaraldehyde-Fixed Fibroblast Monolayers
Confluent cultures were subcultured in a 1 :2 ratio andassayed after 24 h for SF antigen in the
cell extracts and culture media. Cellular SF antigen was solubilized with a solution contain-
ing 8 M,urea, 1% Triton X-100, 0.02% sodium azide, and 1 mM phenylmethylsulphonyl-flu-
oride (2) for the assays, about 250 pl ofextract per culture . All extracts were adjusted to 1
mg cellular protein per ml .
* Mean of duplicate assays on two samples .
FiG. 2 .
￿
Immunodiffusion in agarose . (A) Normal human serum, (B) Concentrated medium
from human fibroblast cultures . (C) Human fibroblasts extracted with 8M urea and 1% Triton
X-100 . (D) Concentrated medium from SV40-transformed fibroblast cultures . (E) SV40-trans-
formed fibroblasts extracted with 8 M urea and 1% Triton X-100 . (F) Fetal calf serum . Center
well : sheep anti-SF serum .
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Sample cpm bound* SF antigen
U
Control 1,010 0
Normal human serum 100 % 108 1,000
10 % 301 100
1 % 526 10
0.1% 930 1
Calfserum 10 % 982 < 1
Cellextracts
Normal
Fibroblast WI-38 521 10
MRC-5 452 17
IHM 433 21
Amnion (primary) 931 1
Transformed
Fibroblast WI-38NA-13 983 <1
WI-SV40 991 <1
Amnion WI-SH 1,036 <1
U 1,080 < 1
Epithelial HeLa 1,209 <1
(carcinoma) KB 1,115 <1
Spent culturemedium
Normal fibroblast
MRC-5 441 19
WI-38 480 14
SV40-transformed fibroblasts
WI-38NA-13 605 6
WI-SV40 630 5
Control medium 991 < 1534
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not show SF antigen on cell surface, but it is produced to the culture medium (in
preparation) . Progress in understanding the significance of this change to the
transformed state obviously calls for further work.
It would be important to know how SF antigen molecules reach a soluble state
when shed from normal cells and why they are not retained at all by the
malignant cell surface . It has been shown that transformed cells in culture
produce a serine protease that is measured by its ability to convert serum
plasminogen to the protease plasmin (13) . Proteolysis as the mechanism of the
splitting of SF antigen from the cell surface thus is a possibility .
Summary
Normal human fibroblasts contain a cell type-specific glycoprotein antigen
(SF) that is known to be slowly shed into the medium and to be present also in
human serum. Immunofluorescence with anti-SF antibodies showed that SF
antigen has a highly nonrandom fibrillar distribution in surface of normal
fibroblasts. Simian virus 40-transformed fibroblasts also produced the SF
antigen, as shown by radioimmunoassay or immunodiffusion tests, but it was not
retained by the surface of these cells . This creates a major difference between the
surfaces of normal and malignant cells .
Receiued for publication 31 March 1975 .
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